SPEAKER CONFIRMATION
Please complete the information below to confirm your participation at the 8th Asia-Pacific Glaucoma Congress on 24-26 July 2026 at Suntec Singapore Convention & Exhibition Centre.
1. Invited Speaker / Chair Response
- Invited Speaker / Chair Response
- Decline invitation to participate
2. Contact Details (please complete this section only if you are accepting the invitation to participate)
The information provided in this section will be used to contact you andmay be included in publicity materials for the Summit.
| Title: | Please select accordingly. | |||
| Full name: (Please underline last name) |
Jella An | |||
| Institution: | Storm Eye Institute, Medical University of South Carolina | |||
| Designation: | MD, MBA | |||
| Department: | Ophthalmology | |||
| Profession: | Professor of Ophthalmology, Glaucoma Fellowship Director |
Professional Number: (if applicable for Singapore registered doctors and Allied Health Professionals only) |
||
| Contact: | 1-573-529-1077 | (Mobile) For contacting onsite |
(Office) | |
| Email: | Anjella.s@gmail.com | |||
| Secretary Contact: | ||||
| Country: | USA | |||
| Dietary Preference: | ☒ No special requirement ☐ Others, Please indicate ____________________ |
|||
Please provide the title of your presentation(s). These may be included in publicity materials to provide more information about your presentation(s).
Avoiding and Managing Tube Exposure in Glaucoma Drainage Device Surgery
Presentation Abstract (no more than 150 words): Tube exposure is an uncommon but potentially sight-threatening complication of glaucoma drainage device surgery because of the associated risk of infection and surgical failure. This focused presentation provides a practical overview of strategies to prevent and manage tube exposure in routine clinical practice. Key preventive principles include optimal implant positioning, creation of a long intrascleral tube tunnel, appropriate patch graft selection, and meticulous conjunctival handling to preserve tissue integrity and vascularity. Important patient- and surgery-related risk factors will be briefly reviewed to support preoperative planning and risk stratification. A simplified stepwise management algorithm will then be presented, outlining indications for conjunctival advancement with graft revision, tube repositioning or shortening, and device explantation in the presence of infection. Emphasis will be placed on early detection and timely intervention to reduce recurrence and improve long-term surgical outcomes.
4. Biosketch
Please provide us with the following detailsto be published in the publicity materials:
- A short biosketch (no more than100words), and
- A professionally takenhead and shoulders portrait photo (high resolution in either jpeg or png format)
Please note that some content may be edited or summarised due to space requirements. No content will be added or altered without your approval.
Actual Biosketch:
Dr. Jella An is Professor of Ophthalmology and Glaucoma Fellowship Director at the Storm Eye Institute, Medical University of South Carolina, USA. Her clinical expertise includes micro-invasive glaucoma surgery, sustained-release drug delivery, and complex cataract and glaucoma care. She serves as principal investigator for multiple clinical trials and has published extensively in peer-reviewed journals. An internationally invited speaker and committed educator, Dr. An focuses on advancing safer, earlier glaucoma treatment while mentoring the next generation of glaucoma specialists through rigorous clinical training and research mentorship
